Email Updates

Search form

You are here

30 AUGUST 2019 VOLUME 20 ISSUE 33

Media Coverage

  • A survey of close to 128,0000 gay and bisexual men living across Europe show that just 3.3 percent have ever taken pre-exposure prophylaxis (PrEP), although 7 percent had tried to obtain it and 45 percent would be likely to use it if it were available and affordable.

    August 30, 2019
    aidsmap
  • Women at high risk for HIV infection can use any form of reversible hormonal contraception without any restrictions, including progestogen-only injectables, implants and intrauterine devices (IUDs), the World Health Organization (WHO) said. All forms of hormonal birth control are now classified as category 1 ("use the method in any circumstances") under the WHO's Medical Eligibility Criteria for Contraceptive Use (MEC) guideline.

    August 29, 2019
    MedPage Today
  • Although US guidelines have recommended PrEP for all high-risk individuals since 2014, fewer than 200,000 of the 1.2 million eligible Americans are enrolled in a PrEP program. The burden of inadequate coverage is borne disproportionately by the nation’s most vulnerable communities.

    August 29, 2019
    Health Affairs
  • The acknowledgment comes as a new public health report shows the city continues to struggle to end an epidemic affecting nearly 2 percent of the population, one of the highest rates in the country.

    August 29, 2019
    General
    Washington Post
  • The combined number of people found to be infected with HIV or diagnosed with AIDS in Japan fell for the second straight year in 2018, the health ministry said Thursday. The total stood at 1,317, down by 72 from the previous year, the ministry said.

    August 29, 2019
    General
    The Japan Times
  • Communities need to be involved in research — not just as participants, but also in shaping the research project, say AVAC and UNAIDS' Good Participatory Practices guidelines (GPP). But how are these guidelines implemented, and what is the outcome? Researchers shared their experiences at the International AIDS Society Conference in July.

    August 28, 2019
    General
    The Body Pro
  • The ads don't have anything new to say about the safety of tenofovir-containing drugs like Truvada. Any person who has begun a regimen with Truvada has long been informed that it may affect kidney function or bone density. But these ads also claim that Gilead, the maker of these drugs, might be liable if you've experienced any of these detrimental side effects.

    August 27, 2019
    TheBody.com
  • “The gender gap in HIV epidemiology is also large for mortality, where HIV/AIDS mortality is three times as high in men as in women," said Kasey Fu, director of epidemiology at GlobalData. "The data also suggest that the gender gap is widening.”

    August 27, 2019
    HIV Plus Mag
  • While it is too early to project the full impact of Planned Parenthood’s withdrawal from Title X, we know that the landscape of sexual and reproductive health service delivery in the US will change. Budget cuts to Planned Parenthood health centers may force reductions in client load and service delivery, or site closures.

    August 27, 2019
    General
    Advocate
  • Michael Johnson, a former college athlete convicted in 2015 of not disclosing his HIV-positive status to sexual partners, was released on parole from a Missouri prison last month. Mr. Johnson, who is gay and black, had maintained his innocence, and there was no proof that he had transmitted the virus. And yet that didn’t seem to matter in the court of public opinion, or in the court of law.

    August 26, 2019
    General
    New York Times
  • Mary Banda – not her real name — is a 35-year-old HIV positive sex worker from neighboring Zambia who cannot afford life-prolonging anti-retroviral drugs. Like many sex workers living with HIV in Botswana, she also cannot afford to travel back home to receive free treatment. That is why Banda welcomes legislation before the Botswana cabinet that, if passed, would provide free ARVs to HIV positive foreigners.

    August 26, 2019
    VOA
  • Global experts are going to share research on HIV vaccines and cures in a meeting that will bring together over ten thousand delegates in Kigali in December. The meeting dubbed the International Conference on AIDS and STIs in Africa (ICASA) will bring together the world’s leading scientists, policymakers, activists, people living with HIV, government leaders – as well as a number of heads of state and civil society representatives.

    August 25, 2019
    The New Times

Published Research

Announcements